Semis Just Split In Two. Tonight Decides Everything!
6 extracted signals · 6 resolved · 0 still active
Arete Trading Independent analyst profile- Source published
- 28 Jul 2026, 21:52 UTC
- Recorded by Tahlil Plus
- 28 Jul 2026, 22:22 UTC

AI-generated source summary
The analysis focuses on key market movements and earnings reports, highlighting the performance of several major stocks and ETFs. SPY shows a bullish trend, targeting 750 with a fail bound at 730. QQQ is exhibiting a bearish trend, with a target of 700 and a fail bound at 660. XLF demonstrates a bullish sentiment, aiming for 58 with a fail bound at 56.5. SKHY is in a bearish trend, with a target of 135 and a fail bound at 130. MU shows a bullish outlook, targeting 850 and failing below 800. SNDK is bearish, with a target of 1100 and a failure below 1050. AMGN displays a bullish trend, targeting 400 and failing below 370. The overall market sentiment is mixed, with some sectors showing strength while others indicate weakness, influenced by upcoming earnings and interest rate decisions.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source






Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
6 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Arete Trading
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.